Maureen Horton, MD
Enriched profilePulmonologist (Internal Medicine – Pulmonary Disease / Critical Care Medicine) · Unknown current institutional affiliation
Maureen Horton is Pulmonologist (Internal Medicine – Pulmonary Disease / Critical Care Medicine) at Unknown current institutional affiliation. OpenAlex indexes 127 publications with 9,648 citations (h-index 47); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Maureen R. Horton, MD, is Pulmonologist (Internal Medicine – Pulmonary Disease / Critical Care Medicine) at Unknown current institutional affiliation (relocated from Johns Hopkins University School of Medicine to San Francisco, CA; no organization name found attached to current NPI practice address). The public record shows 127 publications with 9,648 citations (h-index 47), centered on Idiopathic Pulmonary Fibrosis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 1 companies.
- Top research focus: Idiopathic Pulmonary Fibrosis
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
Sponsor: Vicore Pharma AB
- Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
Sponsor: Johns Hopkins University
Industry payments
Updated 27 Aug 2026
1 company reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20222 payments
- Boehringer Ingelheim International GmbHProgram year20213 payments
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
54.5%Corticosteroid54.5%Prednisone100%Part D<11 patientsNervous system
45.5%Gabapentinoids45.5%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune dysregulation as a driver of idiopathic pulmonary fibrosis
Journal of Clinical Investigation
2021 - Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice
Journal of Clinical Investigation
2021 - mTORC1 Signaling Regulates Proinflammatory Macrophage Function and Metabolism
The Journal of Immunology
2021 - Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Journal of Clinical Investigation
2020
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/maureen-horton-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
data.the-asci.org/controllers/asci/DirectoryController.php
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- Board Certified
Internal Medicine, Pulmonary Disease, and Critical Care Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →data.the-asci.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine (historical; California medical license active 2022-2028 suggests relocation …
2028provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →data.the-asci.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm